Senescence, apoptosis and therapy — cutting the lifelines of cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Link
http://www.nature.com/articles/nrc1044.pdf
Reference120 articles.
1. Lane, D. P. Cancer: p53, guardian of the genome. Nature 358, 15–16 (1992).
2. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997).
3. Schmitt, C. A. et al. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1, 289–298 (2002). Apoptosis is the sole p53 effector function selected against during MYC -driven lymphomagenesis, whereas chromosomal instability or checkpoint defects merely occurred as byproducts of p53 loss.
4. Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349–352 (1998).
5. Kiyono, T. et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88 (1998).
Cited by 252 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis;Canadian Journal of Physiology and Pharmacology;2024-01-01
2. Oridonin-induced ferroptosis and apoptosis: a dual approach to suppress the growth of osteosarcoma cell;2023-12-12
3. Hypusination-induced DHPS/eIF5A pathway as a new therapeutic strategy for human diseases: A mechanistic review and structural classification of DHPS inhibitors;Biomedicine & Pharmacotherapy;2023-11
4. PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis;CAN J PHYSIOL PHARM;2023
5. Role of p53, Cancer Stem Cells, and Cellular Senescence in Radiation Response;International Journal of Biomedicine;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3